We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Featured News

 

Latest News

Vitamins could lead to the Design of Novel Drugs to Combat Malaria
News   Jan 27, 2012

The research will enable scientists to learn more about the nature of the enzymes required for vitamin biosynthesis by the malaria causing pathogen Plasmodium.

READ MORE

CRB Signs Agreement with Life Technologies
News   Jan 20, 2012

Cambridge Research Biochemicals sign an extension to its Supply & Licence Agreement with Life Technologies - Molecular Probes, significantly expanding its dye labelling offering.

READ MORE

NIH Study Shows 32 Million Americans Have AutoAntibodies that Target their Own Tissues
News   Jan 16, 2012

Researchers in Gainesville at the University of Florida also participated in the study.

READ MORE

Professor Dermot Kelleher Named as Principal of the Faculty of Medicine at ICL
News   Jan 16, 2012

Professor Kelleher is one of Ireland's foremost medical leaders and a pioneer in the field of immune response and infectious disease.

READ MORE

NIH Scientists find cause of Rare Immune Disease
News   Jan 13, 2012

The genetic mutation was found to lead to cold allergy, immune deficiency and autoimmunity.

READ MORE

OBT Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
News   Jan 12, 2012

Dr Begley brings extensive knowledge and expertise to OBT at an exciting phase in the company’s development.

READ MORE

First Trial of a New Hepatitis C Vaccine Shows Promise
News   Jan 05, 2012

A new vaccine against the chronic liver disease hepatitis C has shown promising results in a first clinical trial in humans, Oxford University researchers report.

READ MORE

NexImmune Makes Appointments to its Board
News   Jan 05, 2012

Kenneth Carter, PhD and Professor Jonathan Schneck, MD, PhD, have been appointed company President and Chief Executive Officer and Chairman of the company's Clinical and Scientific Advisory Board, respectively.

READ MORE

Thomas Szucs Elected New Chairman of Intercell’s Supervisory Board
News   Jan 03, 2012

Thomas Szucs takes over the function from Michel Gréco, who resigned from the role but still remains a member of the Supervisory Board.

READ MORE

HIV Study Named 2011 Breakthrough of the Year by Science
News   Dec 23, 2011

The HPTN 052 clinical trial, an international HIV prevention trial, has been chosen by the journal Science as the 2011 Breakthrough of the Year.

READ MORE

 
Advertisement